West Pharmaceutical Services forecast full-year results below analysts' estimates on Thursday after the company missed fourth-quarter revenue expectations, hurt by weak demand for its medical equip...

West Pharmaceutical's (WST) fourth-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bott...

Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the e...

Century-old West Pharmaceutical Services has a strong history of growing its top and bottom lines. It remains a growth stock, with very good margins, seasoned management and a proven strategy. It w...

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.

West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Quintin Lai - Vice President of Investor Relations Eric Green - Pres...

The headline numbers for West Pharmaceutical (WST) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wa...

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.03 per share a year ...

Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger dollar.

West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and botto...

West Pharmaceutical Services, Inc. has experienced a 60% gain in its stock price so far in 2023 but has hit some recent technical headwinds. Insiders have also sold a significant number of shares i...

Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion.

West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock.

West Pharmaceutical Services has seen a 60% rally in its stock price since December 2022, outperforming the S&P 500. Momentum in financials shows a decline in top line sales but strong growth in co...